Sleep in psychiatric disorders: Where are we now?

Canadian Journal of Psychiatry

Volumn 55, Issue 7, 2010, Pages 403-412

  Lee, Elliott Kyung ^a,b   Douglass, Alan B ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ROYAL OTTAWA HOSPITAL   (Canada)

Author keywords

Alcohol; Antidepressant; Antipsychotic; Anxiety; Opioid; Psychiatric disorders; REM sleep; Schizophrenia; Sleep; Slow wave sleep

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE; CANNABINOID; CLOZAPINE; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; FLUVOXAMINE; GABAPENTIN; HALOPERIDOL; MELATONIN; MIRTAZAPINE; NABILONE; OLANZAPINE; OPIATE; PALIPERIDONE; PRAMIPEXOLE; PRASTERONE SULFATE; PRAZOSIN; QUETIAPINE; RISPERIDONE; ROPINIROLE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TIOTIXENE; TOPIRAMATE; TRAZODONE; UNINDEXED DRUG; VENLAFAXINE; ZIPRASIDONE;

AGING; ALCOHOL CONSUMPTION; ANXIETY DISORDER; CARDIOVASCULAR DISEASE; CEREBROSPINAL FLUID; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PAIN; CIRCADIAN RHYTHM; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DOPAMINERGIC ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; FATIGUE; GENERALIZED ANXIETY DISORDER; HEART DISEASE; HYPOTHYROIDISM; INSOMNIA; KIDNEY FAILURE; MEMORY CONSOLIDATION; MENTAL DISEASE; NARCOLEPSY; NEOPLASM; NEUROCHEMISTRY; NIGHTMARE; OBESITY; PANIC; PARASOMNIA; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLOW WAVE SLEEP; SNORING; SOMNOLENCE; STROKE; SUBSTANCE ABUSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 77956892606     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371005500703     Document Type: Review

References (150)

1. Horne J. Human slow wave sleep: a review and appraisal of recent findings, with implications for sleep functions, and psychiatric illness. Experientia. 1992;48:941-954.
2. Tononi G, Cirelli C. Sleep function and synaptic homeostasis. Sleep Med Rev. 2006;10:49-62.
3. Poulin J, Daoust AM, Forest G, et al. Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia. Schizophr Res. 2003;62:147-153.
4. Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med. 2007;8 Suppl 4:S27-S34.
5. Cartwright R, Agargun MY, Kirkby J, et al. Relation of dreams to waking concerns. Psychiatry Res. 2006;141:261-270.
6. Moffit A, Kramer M, Hoffman R, editors. The selective mood regulatory function of dreaming: an upate and revision. New York (NY): State University of New York Press; 1993.
7. Walker MP. The role of sleep in cognition and emotion. Ann N Y Acad Sci. 2009;1156:168-197.
8. Benca RM, Obermeyer WH, Thisted RA, et al. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry. 1992;49:651-668; discussion 669-670.
9. Chouinard S, Poulin J, Stip E, et al. Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull. 2004;30:957-967.
10. Dencker SJ, Malm U, Lepp M. Schizophrenic relapse after drug withdrawal is predictable. Acta Psychiatr Scand. 1986;73:181-185.
11. Zarcone VP Jr, Benson KL, Berger PA. Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry. 1987;44:45-48.
12. Benson KL. Sleep in schizophrenia: impairments, correlates, and treatment. Psychiatr Clin North Am. 2006;29:1033-1045; abstract ix-x.
13. Keshavan MS, Reynolds CF 3rd, Miewald MJ, et al. Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data. Arch Gen Psychiatry. 1998;55:443-448.
14. Benington JH, Heller HC. Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol. 1995;45:347-360.
15. Marshall L, Helgadottir H, Molle M, et al. Boosting slow oscillations during sleep potentiates memory. Nature. 2006;444:610-613.
16. Keshavan MS, Miewald J, Haas G, et al. Slow-wave sleep and symptomatology in schizophrenia and related psychotic disorders. J Psychiatr Res. 1995;29:303-314.
17. Tandon R, Shipley JE, Taylor S, et al. Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment. Arch Gen Psychiatry. 1992;49:185-194.
18. Ganguli R, Reynolds CF 3rd, Kupfer DJ. Electroencephalographic sleep in young, never-medicated schizophrenics. A comparison with delusional and nondelusional depressives and with healthy controls. Arch Gen Psychiatry. 1987;44:36-44.
19. Kato M, Kajimura N, Okuma T, et al. Association between delta waves during sleep and negative symptoms in schizophrenia. Pharmaco-eeg studies by using structurally different hypnotics. Neuropsychobiology. 1999;39:165-172.
20. Benson KL, Sullivan EV, Lim KO, et al. Slow wave sleep and computed tomographic measures of brain morphology in schizophrenia. Psychiatry Res. 1996;60:125-134.
21. van Kammen DP, van Kammen WB, Peters J, et al. Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia. Neuropsychopharmacology. 1988;1:265-271.
22. Aldrich MS. Diagnostic aspects of narcolepsy. Neurology. 1998;50:S2-S7.
23. Kishi Y, Konishi S, Koizumi S, et al. Schizophrenia and narcolepsy: a review with a case report. Psychiatry Clin Neurosci. 2004;58:117-124.
24. Douglass AB, Shipley JE, Haines RF, et al Schizophrenia, narcolepsy, and HLA-DR15, DQ6. Biol Psychiatry. 1993;34:773-780.
25. Douglass AB. Narcolepsy: differential diagnosis or etiology in some cases of bipolar disorder and schizophrenia? CNS Spectr. 2003;8:120-126.
26. Fortuyn HA, Lappenschaar GA, Nienhuis FJ, et al. Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatry. 2009;31:146-154.
27. Canadian Psychiatric Association. Clinical practice guidelines. Treatment of schizophrenia. Can J Psychiatry. 2005;50(13 Suppl 1):7S-57S.
28. Lublin H, Eberhard J, Levander S. Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics. Int Clin Psychopharmacol. 2005;20:183-198.
29. Gao K, Ganocy SJ, Gajwani P, et al. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. J Clin Psychiatry. 2008;69:302-309.
30. Krystal AD, Goforth HW, Roth T. Effects of antipsychotic medications on sleep in schizophrenia. Int Clin Psychopharmacol. 2008;23:150-160.
31. Partinen M, Telakivi T. Epidemiology of obstructive sleep apnea syndrome. Sleep. 1992;15:S1-S4.
32. Dennis JL, Crisham KP. Chronic assaultive behavior improved with sleep apnea treatment. J Clin Psychiatry. 2001;62:571-572.
33. Kraus T, Schuld A, Pollmacher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol. 1999;19:478-479.
34. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry. 2002;35:109-111.
35. Urbano MR, Ware JC. Restless legs syndrome caused by quetiapine successfully treated with ropinirole in 2 patients with bipolar disorder. J Clin Psychopharmacol. 2008;28:704-705.
36. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, et al. Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients. Rev Invest Clin. 2004;56:345-350.
37. Yamashita H, Morinobu S, Yamawaki S, et al. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res. 2002;109:137-142.
38. Luthringer R, Staner L, Noel N, et al. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol. 2007;22:299-308.
39. Ohayon MM, Roth T. What are the contributing factors for insomnia in the general population? J Psychosom Res. 2001;51:745-755.
40. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101-119.
41. Hening WA, Allen RP, Earley CJ, et al. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004;27:560-583.
42. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160:2137-2141.
43. Lee HB, Hening WA, Allen RP, et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci. 2008;20:101-105.
44. Rottach KG, Schaner BM, Kirch MH, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res. 2008;43:70-75.
45. Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry. 2005;58:510-514.
46. Lee JJ, Erdos J, Wilkosz MF, et al. Bupropion as a possible treatment option for restless legs syndrome. Ann Pharmacother. 2009;43:370-374.
47. Ulfberg J, Nystrom B, Carter N, et al. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16:1159-1163.
48. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000;54:1064-1068.
49. Silber MH, Ehrenberg BL, Allen RP, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc. 2004;79:916-922.
50. Papadimitriou GN, Linkowski P. Sleep disturbance in anxiety disorders. Int Rev Psychiatry. 2005;17:229-236.
51. Mellman TA. Sleep and anxiety disorders. Psychiatr Clin North Am. 2006;29:1047-1058; abstract x.
52. Saletu-Zyhlarz G, Saletu B, Anderer P, et al. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology. 1997;36:117-129.
53. Craske MG, Lang AJ, Tsao JC, et al. Reactivity to interoceptive cues in nocturnal panic. J Behav Ther Exp Psychiatry. 2001;32:173-190.
54. Craske MG, Tsao JC. Assessment and treatment of nocturnal panic attacks. Sleep Med Rev. 2005;9:173-184.
55. Aikins DE, Craske MG. Sleep-based heart period variability in panic disorder with and without nocturnal panic attacks. J Anxiety Disord. 2008;22:453-463.
56. Mellman TA, Uhde TW. Electroencephalographic sleep in panic disorder. A focus on sleep-related panic attacks. Arch Gen Psychiatry. 1989;46:178-184.
57. Germain A, Nielsen TA. Sleep pathophysiology in posttraumatic stress disorder and idiopathic nightmare sufferers. Biol Psychiatry. 2003;54:1092-1098.
58. Kobayashi I, Boarts JM, Delahanty DL. Polysomnographically measured sleep abnormalities in PTSD: a meta-analytic review. Psychophysiology. 2007;44:660-669.
59. Neylan TC, Otte C, Yehuda R, et al. Neuroendocrine regulation of sleep disturbances in PTSD. Ann N Y Acad Sci. 2006;1071:203-215.
60. Risbrough VB, Stein MB. Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav. 2006;50:550-561.
61. Mellman TA, David D, Kulick-Bell R, et al. Sleep disturbance and its relationship to psychiatric morbidity after Hurricane Andrew. Am J Psychiatry. 1995;152:1659-1663.
62. Breslau N, Roth T, Burduvali E, et al. Sleep in lifetime posttraumatic stress disorder: a community-based polysomnographic study. Arch Gen Psychiatry. 2004;61:508-516.
63. Mellman TA, Kulick-Bell R, Ashlock LE, et al. Sleep events among veterans with combat-related posttraumatic stress disorder. Am J Psychiatry. 1995;152:110-115.
64. Husain AM, Miller PP, Carwile ST. REM sleep behavior disorder: potential relationship to post-traumatic stress disorder. J Clin Neurophysiol. 2001;18:148-157.
65. Ross RJ, Ball WA, Dinges DF, et al. Motor dysfunction during sleep in posttraumatic stress disorder. Sleep. 1994;17:723-732.
66. Leskin GA, Woodward SH, Young HE, et al. Effects of comorbid diagnoses on sleep disturbance in PTSD. J Psychiatr Res. 2002;36:449-452.
67. Spoormaker VI, Montgomery P. Disturbed sleep in post-traumatic stress disorder: secondary symptom or core feature? Sleep Med Rev. 2008;12:169-184.
68. Lamarche LJ, De Koninck J. Sleep disturbance in adults with posttraumatic stress disorder: a review. J Clin Psychiatry. 2007;68:1257-1270.
69. Raboni MR, Tufik S, Suchecki D. Treatment of PTSD by eye movement desensitization reprocessing (EMDR) improves sleep quality, quality of life, and perception of stress. Ann N Y Acad Sci. 2006;1071:508-513.
70. Krakow B, Melendrez D, Pedersen B, et al. Complex insomnia: insomnia and sleep-disordered breathing in a consecutive series of crime victims with nightmares and PTSD. Biol Psychiatry. 2001;49:948-953.
71. Krakow B, Lowry C, Germain A, et al. A retrospective study on improvements in nightmares and post-traumatic stress disorder following treatment for co-morbid sleep-disordered breathing. J Psychosom Res. 2000;49:291-298.
72. Krakow B, Melendrez D, Warner TD, et al. Signs and symptoms of sleep-disordered breathing in trauma survivors: a matched comparison with classic sleep apnea patients. J Nerv Ment Dis. 2006;194:433-439.
73. Germain A, Buysse DJ, Nofzinger E. Sleep-specific mechanisms underlying posttraumatic stress disorder: integrative review and neurobiological hypotheses. Sleep Med Rev. 2008;12:185-195.
74. Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61:928-934.
75. Miller LJ. Prazosin for the treatment of posttraumatic stress disorder sleep disturbances. Pharmacotherapy. 2008;28:656-666.
76. Warner MD, Dorn MR, Peabody CA. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry. 2001;34:128-131.
77. Lewis JD. Mirtazapine for PTSD nightmares. Am J Psychiatry. 2002;159:1948-1949.
78. States JH, St Dennis CD. Chronic sleep disruption and the reexperiencing cluster of posttraumatic stress disorder symptoms are improved by olanzapine: brief review of the literature and a case-based series. Prim Care Companion J Clin Psychiatry. 2003;5:74-79.
79. David D, De Faria L, Mellman TA. Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD. Depress Anxiety. 2006;23:489-491.
80. Robert S, Hamner MB, Kose S, et al. Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study. J Clin Psychopharmacol. 2005;25:387-388.
81. Lambert MT. Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans. Int Clin Psychopharmacol. 2006;21:185-187.
82. Berlant J, van Kammen DP. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report. J Clin Psychiatry. 2002;63:15-20.
83. Hamner MB, Brodrick PS, Labbate LA. Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry. 2001;13:141-146.
84. Fraser GA. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther. 2009;15:84-88.
85. Sageman S, Brown RP. 3-acetyl-7-oxo-dehydroepiandrosterone for healing treatment-resistant posttraumatic stress disorder in women: 5 case reports. J Clin Psychiatry. 2006;67:493-496.
86. Berger W, Mendlowicz MV, Marques-Portella C, et al. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:169-180.
87. Neylan TC, Metzler TJ, Schoenfeld FB, et al. Fluvoxamine and sleep disturbances in posttraumatic stress disorder. J Trauma Stress. 2001;14:461-467.
88. Mellman TA, Bustamante V, David D, et al. Hypnotic medication in the aftermath of trauma. J Clin Psychiatry. 2002;63:1183-1184.
89. Wills L, Garcia J. Parasomnias: epidemiology and management. CNS Drugs. 2002;16:803-810.
90. Espiritu JR. Aging-related sleep changes. Clin Geriatr Med. 2008;24:1-14, v.
91. Ancoli-Israel S. Sleep problems in older adults: putting myths to bed. Geriatrics. 1997;52:20-30.
92. Barbar SI, Enright PL, Boyle P, et al. Sleep disturbances and their correlates in elderly Japanese American men residing in Hawaii. J Gerontol A Biol Sci Med Sci. 2000;55:M406-M411.
93. Crenshaw MC, Edinger JD. Slow-wave sleep and waking cognitive performance among older adults with and without insomnia complaints. Physiol Behav. 1999;66:485-492.
94. Dew MA, Hoch CC, Buysse DJ, et al. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med. 2003;65:63-73.
95. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6:97-111.
96. Rediehs MH, Reis JS, Creason NS. Sleep in old age: focus on gender differences. Sleep. 1990;13:410-424.
97. Foley DJ, Monjan A, Simonsick EM, et al. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep. 1999;22 Suppl 2:S366-S372.
98. Ancoli-Israel S, Ayalon L, Salzman C. Sleep in the elderly: normal variations and common sleep disorders. Harv Rev Psychiatry. 2008;16:279-286.
99. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235.
100. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med. 2002;162:893-900. (Pubitemid 34299121)
101. Norman D, Loredo JS. Obstructive sleep apnea in older adults. Clin Geriatr Med. 2008;24:151-165, ix.
102. Ancoli-Israel S, Klauber MR, Butters N, et al. Dementia in institutionalized elderly: relation to sleep apnea. J Am Geriatr Soc. 1991;39:258-263.
103. Groth M. Sleep apnea in the elderly. Clin Geriatr Med. 2005;21:701-712, vi.
104. Aloia MS, Ilniczky N, Di Dio P, et al. Neuropsychological changes and treatment compliance in older adults with sleep apnea. J Psychosom Res. 2003;54:71-76.
105. Haas DC, Foster GL, Nieto FJ, et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation. 2005;111:614-621.
106. Pack AI, Maislin G. Who should get treated for sleep apnea? Ann Intern Med. 2001;134:1065-1067.
107. Ayalon L, Ancoli-Israel S, Stepnowsky C, et al. Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea. Am J Geriatr Psychiatry. 2006;14:176-180. (Pubitemid 43227641)
108. Hornyak M, Trenkwalder C. Restless legs syndrome and periodic limb movement disorder in the elderly. J Psychosom Res. 2004;56:543-548.
109. Driver-Dunckley ED, Noble BN, Hentz JG, et al. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol. 2007;30:249-255.
110. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123(Pt 2):331-339.
111. Stiasny-Kolster K, Doerr Y, Möller JC, et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain. 2005;128:126-137.
112. Britton TC, Chaudhuri KR. REM-sleep behavior disorder and the risk of developing Parkinson disease or dementia. Neurology. 2009;72(15):1294-1295.
113. Postuma RB, Gagnon JF, Vendette M, . Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009;72(15):1296-1300.
114. Louden MB, Morehead MA, Schmidt HS. Activation by selegiline (Eldepryle) of REM sleep behavior disorder in parkinsonism. W V Med J. 1995;91(3):101.
115. Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep. 2004;27:317-321.
116. Onofrj M, Luciano AL, Thomas A, et al. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology. 2003;60:113-115.
117. Gagnon JF, Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology. 2006;67:742-747.
118. Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003;4:281-284.
119. Schnelle JF, Cruise PA, Alessi CA, et al. Sleep hygiene in physically dependent nursing home residents: behavioral and environmental intervention implications. Sleep. 1998;21:515-523.
120. Yesavage JA, Friedman L, Ancoli-Israel S, et al. Development of diagnostic criteria for defining sleep disturbance in Alzheimer's disease. J Geriatr Psychiatry Neurol. 2003;16:131-139.
121. Mishima K, Tozawa T, Satoh K, et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol Psychiatry. 1999;45:417-421.
122. Garfinkel D, Laudon M, Nof D, et al. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet. 1995;346:541-544.
123. Gehrman PR, Connor DJ, Martin JL, et al. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry. 2009;17:166-169.
124. Bloom HG, Ahmed I, Alessi CA, et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc. 2009;57:761-789.
125. Alessi CA, Schnelle JF. Approach to sleep disorders in the nursing home setting. REVIEW ARTICLE. Sleep Med Rev. 2000;4:45-56.
126. Ancoli-Israel S, Gehrman P, Martin JL, et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav Sleep Med. 2003;1:22-36.
127. Morin CM, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA. 1999;281:991-999.
128. Pressman MR. Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications. Sleep Med Rev. 2007;11:5-30; discussion 1-3.
129. Costa e Silva JA, Chase M, Sartorius N, et al. Special report from a symposium held by the World Health Organization and the World Federation of Sleep Research Societies: an overview of insomnias and related disorders - recognition, epidemiology, and rational management. Sleep. 1996;19:412-416.
130. Stein MD, Friedmann PD. Disturbed sleep and its relationship to alcohol use. Subst Abus. 2005;26:1-13.
131. Drummond SP, Gillin JC, Smith TL, et al. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res. 1998;22:1796-1802.
132. Brower KJ, Aldrich MS, Robinson EA, et al. Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry. 2001;158:399-404.
133. Clark CP, Gillin JC, Golshan S, et al. Increased REM sleep density at admission predicts relapse by three months in primary alcoholics with a lifetime diagnosis of secondary depression. Biol Psychiatry. 1998;43:601-607.
134. Le Bon O, Murphy JR, Staner L, et al. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations. J Clin Psychopharmacol. 2003;23:377-383.
135. Malcolm R, Myrick H, Roberts J, et al. The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict. 2002;11:141-150.
136. Staner L, Boeijinga P, Danel T, et al. Effects of acamprosate on sleep during alcohol withdrawal: a double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res. 2006;30:1492-1499.
137. Malcolm R, Myrick LH, Veatch LM, et al. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. J Clin Sleep Med. 2007;3:24-32.
138. Andersen ML, Poyares D, Alves RS, et al. Sexsomnia: abnormal sexual behavior during sleep. Brain Res Rev. 2007;56:271-282.
139. Wang D, Teichtahl H. Opioids, sleep architecture and sleep-disordered breathing. Sleep Med Rev. 2007;11:35-46.
140. Howe RC, Hegge FW, Phillips JL. Acute heroin abstinence in man: II. Alterations in rapid eye movement (REM) sleep. Drug Alcohol Depend. 1980;6:149-161.
141. Howe RC, Hegge FW, Phillips JL. Acute heroin abstinence in man: I. Changes in behavior and sleep. Drug Alcohol Depend. 1980;5:341-356.
142. Roehrs T, Hyde M, Blaisdell B, et al. Sleep loss and REM sleep loss are hyperalgesic. Sleep. 2006;29:145-151.
143. Dimsdale JE, Norman D, DeJardin D, et al. The effect of opioids on sleep architecture. J Clin Sleep Med. 2007;3:33-36.
144. Wang D, Teichtahl H, Drummer O, et al. Central sleep apnea in stable methadone maintenance treatment patients. Chest. 2005;128:1348-1356.
145. Webster LR, Choi Y, Desai H, et al. Sleep-disordered breathing and chronic opioid therapy. Pain Med. 2008;9:425-432.
146. Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007;3:455-461.
147. Nicholson AN, Turner C, Stone BM, et al. Effect of Delta-9- tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24:305-313.
148. Murillo-Rodriguez E. The role of the CB1 receptor in the regulation of sleep. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1420-1427.
149. Schierenbeck T, Riemann D, Berger M, et al. Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev. 2008;12:381-389.
150. Budney AJ, Hughes JR, Moore BA, et al. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;161:1967-1977.